| |
|
|
|
| |
|
|
| Industry
Panel Discussion (TBA) |
|
| |
|
|
|
|
|
|
The
Largest East Coast Strategic Partnership and Investment Meeting
for Medical Technology Executives
NEW! Don’t miss the latest updates-directly from the FDA!
Panel, June 24, 2009, 1:30-2:30 pm
Working Successfully With FDA – Priorities Under the New Administration
- Understand the agency’s current thinking on 510(k) clearance
- Learn about CDRH’s new program to reclassify many devices
- Get FDA tips on ensuring data integrity in your clinical trials
Mary Houghton
Executive Editor
The Gray Sheet
Heather S. Rosecrans
Director, 510(k) Staff
FDA Center for Devices and Radiological Health
Michael Marcarelli
Director, Division of Bioresearch Monitoring, Office of Compliance
FDA Center for Devices and Radiological Health
Invest, Partner and Network with THE Most Senior-Level Investors and Regulators in the Business:
Heather S. Rosecrans
Director, 510(k) Staff
FDA Center for Devices and Radiological Health
Michael Marcarelli
Director, Division of Bioresearch Monitoring, Office of Compliance
FDA Center for Devices and Radiological Health
Steven Weinstein
Managing Director
Novartis Venture Funds
John B. Henneman, III
EVP, Finance & Administration and CFO
Integra LifeSciences Corporation
Dennis Crowley
Vice President, Corporate Development
Covidien
Ted Davis
Vice President, Business Development
Wright Medical Technology |
Izi Vruker
Vice President, Research & Development
Depuy-Mitek/Johnson & Johnson
Paul LaViolette
Venture Partner
SV Life Sciences
Matt Rieke
Partner
Quaker Bioventures
Daniel Sheehan
Vice President
Covidien Ventures
Albert Lauritano, MSc, CLP
Director, Business Development
Becton Dickinson (BD)
Anupendra Sharma
Investment Partner
Siemens Venture Capital, Inc.
|
|
Investment-in-Innovation (In3) conferences are the premier forums worldwide for discerning senior executives in the medical device, diagnostics, biotech, and pharmaceutical business development and investment communities to meet and screen promising medical technology companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. Click here to see a video describing why you should attend IN3 conferences:
Launch Video |
| In3
East is simply where you will meet the most important
people in medical technology partnering.
As the largest East Coast strategic partnership and investment
meeting for senior-level medical technology executives,
hundreds of venture capital companies and medical technology
companies gather each year to hear about the latest innovations
and investment opportunities, especially in the following
areas:
- Cardiovascular/Interventional
Cardiology
-
Diagnostics
-
Drug Delivery
- Imaging
-
Minimally Invasive Surgery
-
Nanotechnology
-
Neurostimulation
-
Orthopedics/Spine
-
Peripheral Vascular
-
Stem Cells
-
Stroke Management
-
Wound Management
...
among many other high-growth areas
And
when you’re not networking, you’ll benefit
from any of the following discussed at the meeting:
- Keynote
presentations, on-stage interviews, investment and financing
panel discussions by prominent device industry executives
- Venture
capital dealmaking presentations
-
Buy side panels
- Educational
workshops for start-up companies
- Company
presentations from more than 50 emerging medical technology
companies seeking funding and/or strategic partnership
For
more information, please contact Kristy Grimes at 480-985-9512,
888-202-5939 toll-free in the U.S., or e-mail in3@windhover.com |
|
Advisory Board
Jeffrey
Barnes
General Partner
Oxford Bioscience Partners
Annette
Campbell-White
Senior Managing Member MedVenture Associates
Michael
Carusi
General Partner
Advanced Technology Ventures
Luke
Evnin
General Partner
MPM Capital
Richard
M. Ferrari
Managing Director
DeNovo Ventures
William
T. Harrington
Partner
Three Arch Partners
Ross
A. Jaffe
Managing Director
Versant Ventures
Ellen
Koskinas
Partner
InterWest Partners
Josh
Makower
Venture Partner
NEA
John
Maroney
General Partner
Delphi Ventures
Allan May
Chairman, Founder
Life Science Angels
Managing Director
Emergent Medical Partner
David
Milne
Managing Partner
SV Life Science Advisers
Trevor
J. Moody
Partner
Frazier Healthcare Ventures
Jesse
I Treu
Partner
Domain Associates |
|
|
| back to top |
Program Agenda
| June 23, 2009 |
| 8:00 - 5:00 PM |
Medical Device Investor Day Symposium
Held prior to the In3 East Conference
|
| 5:00 - 7:00 PM |
In3 East Registration & Welcome Reception Essex Ballroom Foyer
|
| 6:00 - 7:00 PM |
Pre-Conference Panel Discussion
Setting the Right Trajectory: Avoiding the 14 Biggest Mistakes Made By Emerging Lifescience Companies
Regulatory decisions have implications far beyond FDA approval. Find out how to avoid regulatory stumbles.
Investors need to be convinced of the business case. Learn the most often overlooked but essential evidence to make the case for investors.
See the 10 slides that should be in every investor presentation and grasp the three critical slides that demonstrate your value proposition the way that investors prefer.
Reimbursement decisions can make or break successful commercialization. Find out the critical decision points and when to make them.
- Nancy Reaven, President, Strategic Health Resources
- Nancy Patterson, President, Strategy Inc.
|
| June 24, 2009 |
| 7:00 - 7:55 AM |
Registration & Continental Breakfast Essex Ballroom Foyer
|
| 8:00 - 8:05 AM |
Welcome/Opening Essex Ballroom South
|
| 8:05 - 9:00 AM |
Keynote Panel Discussion
Getting Funded: What VCs Want-- and Don't Want-- to See in Today's Market
David Cassak, Managing Director, Medical Devices at Elsevier Business Intelligence
Steven Weinstein, Managing Director, Novartis Venture Funds
Paul LaViolette, SV Life Sciences
Daniel Sheehan, Vice President, Covidien Ventures
Matt Rieke, General Partner, Quaker BioVentures
|
| 9:00 - 5:25 PM |
Company Presentations Essex Ballroom South
|
| 9:05 - 9:10 AM |
Moderator
|
| 9:10 - 9:20 AM |
MicroTransponder Inc.
|
| 9:20 - 9:30 AM |
Pico-Tesla Magnetic Therapies, LLC
|
| 9:30 - 9:40 AM |
CardioMag Imaging, Inc.
|
| 9:40 - 9:50 AM |
CoreSpine Technologies
|
| 9:50 - 10:00 AM |
ICON Interventional Systems
|
| 10:00 - 10:10 AM |
Cornova, Inc.
|
| 10:15 - 10:20 AM |
Moderator
|
| 10:20 - 10:30 AM |
CardiAQ Valve Technologies
|
| 10:30 - 10:40 AM |
Invendo Medical GmbH
|
| 10:40 - 10:50 AM |
SquareOne Inc.
|
| 10:50 - 11:00 AM |
Arterain Medical, Inc.
|
| 11:00 - 11:10 AM |
Xylos Corporation
|
| 11:10 - 11:20 AM |
Optasia Medical Ltd.
|
| 11:25 - 11:30 AM |
Moderator
|
| 11:30 - 11:40 AM |
Echo Therapeutics
|
| 11:40 - 11:50 AM |
SynCardia Systems, Inc.
|
| 11:50 - 12:00 PM |
Aura Medsystems, Inc.
|
| 12:00 - 12:10 PM |
NuOrtho Surgical Inc.
|
| 12:10 - 12:20 PM |
Spartan Bioscience Inc.
|
| 12:20 - 12:30 PM |
EyeGate Pharmaceuticals, Inc.
|
| 12:30 - 1:30 PM |
Lunch Essex Ballroom Center
|
| 1:30 - 2:30 PM |
Panel Discussion Essex Ballroom South
Working Successfully With FDA – Priorities Under the New Administration
Understand the agency’s current thinking on 510(k) clearance
Learn about CDRH’s new program to reclassify many devices
Get FDA tips on ensuring data integrity in your clinical trials
- Mary Houghton, Executive Editor, The Gray Sheet (Moderator)
- Heather S. Rosecrans, Dir. of 510(k) Staff, FDA Center for Devices & Radiological Health
- Michael Marcarelli, Dir. of Division of Bioresearch Monitoring, Office of Compliance, FDA Center for Devices and Radiological Health
- Mark DuVal, Director and Managing Partner, DuVal & Associates, P.A.
|
| 2:30 - 2:35 PM |
Moderator
|
| 2:35 - 2:45 PM |
Softscope Medical Technologies
|
| 2:45 - 2:55 PM |
Vivo Metrics
|
| 2:55 - 3:05 PM |
SpinX Technologies, SA
|
| 3:05 - 3:15 PM |
CytoSorbents, Inc.
|
| 3:15 - 3:25 PM |
Replication Medical, Inc. (RMI)
|
| 3:25 - 3:35 PM |
Profound Medical Inc.
|
| 3:40 - 3:45 PM |
Moderator
|
| 3:45 - 3:55 PM |
Axial Biotech
|
| 3:55 - 4:05 PM |
Medical Device Works
|
| 4:05 - 4:15 PM |
MicroMed Cardiovascular, Inc.
|
| 4:15 - 4:25 PM |
ThermalAngel
|
| 4:25 - 4:35 PM |
Methco
|
| 4:35 - 4:45 PM |
Biomedical Photometrics, Inc.
|
| 4:50 - 4:55 PM |
Moderator
|
| 4:55 - 5:05 PM |
MicroPhage Incorporated
|
| 5:05 - 5:15 PM |
Mespere
|
| 5:15 - 5:25 PM |
Spinetronics Antalgic-Trak
|
| 5:25 - 5:35 PM |
DiFUSION Technologies
|
| 5:35 - 5:45 PM |
PLC Medical Systems, Inc.
|
| 5:45 - 6:15 PM |
Sponsor Supported Networking Session
|
| 6:15 - 7:45 PM |
Presenting Company Product Exhibits/Networking Session
|
| June 25, 2009 |
| 8:30 - 9:00 AM |
Registration & Continental Breakfast Essex Ballroom Foyer
|
| 9:00 - 10:15 AM |
State of the Medical Device Industry Address
David Cassak, Managing Director, Devices, Elsevier Business Intelligence
Stephen Levin, Executive Editor, Elsevier Business Intelligence
|
| 10:15 - 10:45 AM |
Networking Break and Check-Out
|
| 10:45 - 10:50 AM |
Moderator
|
| 10:50 - 11:00 AM |
Anulex Technologies
|
| 11:00 - 11:10 AM |
Ankota
|
| 11:10 - 11:20 AM |
Veryan Medical, Ltd.
|
| 11:20 - 11:30 AM |
MiCardia Corporation
|
| 11:30 - 11:40 AM |
Nonatec Medical Systems
|
| 11:40 - 12:40 PM |
Box Lunch Essex Ballroom Center
|
|
| |
| Top
reasons to attend In3 East:
- Catch
up on the state of medical technology investment and partnering
-
Network with peers who face similar challenges in regulatory,
reimbursement and clinical issues for medical devices
-
Benchmark your dealmaking against the best and the brightest
-
Winners and losers: Find out which companies and technologies
are worth the investment
-
Get key trend analysis on medical technology deal structures
-
Maximize your strategic alliance opportunities by meeting
business development leaders who’ll share practical
advice and strategies on how to structure successful deals
- Walk
away with practical, real-life lessons from some of the most
experienced dealmakers in the industry in the medical technology
marketplace
- Attended
by senior-level decision-makers from the investment community
and major medical technology, biopharmaceutical, biotech,
venture capital and other companies
-
More than 50 participating companies
-
10-minute presentations immediately followed by private, one-on-one
meetings with company representatives
-
A range of technologies for such high-growth segments of the
medtech industry as interventional cardiology, spinal and
orthopedic surgery, drug delivery technology, and stroke management
Maximize
your strategic alliance opportunities by hearing C-level, venture
capital and business development executives who share lessons
learned, practical advice and strategies on medical technology
dealmaking.
In3
East has the most senior execs in attendance:
-
Presidents
- CEOs
- Chairmen
- Venture
Partners
- Managing
Directors
- Vice
Presidents/Directors of Business Development, Marketing, New
Technology, Acquisitions, R & D & Sales
- Senior
Investment Analysts/Managers/Directors
If
you're on this list, you must attend this meeting.
-
Established medical technology companies seeking technology
through licensing, partnering and acquisition to broaden or
deepen product lines or build sector strength
- Venture
capitalists and investment bankers
- Medical
device, biotech, biopharmaceutical or other company executives
seeking investments or partnerships
|
| back to top |
Presenting Companies
Ankota (First-Time Presenter)
Wellesley, MA
|
Ankota is the pioneering company in the field of Healthcare Delivery Management (HDM) providing technology to enable home health care providers to provide better patient care while improving operational efficiency by 20-30%. www.ankota.com
|
Anulex Technologies (First-Time Presenter)
Minnetonka, MN
|
Medical technology to repair and seal the soft tissue of the spine (anulus) for patients undergoing a surgical procedure to remove a herniated disc (discectomy).
www.anulex.com
|
Arterain Medical (First-Time Presenter)
Atlanta, GA
|
An early-stage, medical device company focused on the development of a catheter for the treatment of acute ischemic stroke.
www.arterain.com
|
Aura Medsystems, Inc. (First-Time Presenter)
New York, NY
|
Company description coming soon.
|
Axial Biotech
Salt Lake City, UT
|
Focused on developing and commercializing genetic tests and treatment solutions for spinal disorders.
www.axialbiotech.com
|
Biomedical Photometrics, Inc. (First-Time Presenter)
Ontario, Canada
|
Digital clinical pathology systems.www.confocal.com
|
CardiAQ Valve Technologies
Winchester, MA
|
CardiAQ Valve Technologies (CVT) is developing innovative approaches to heart valve replacement and is initially focused on Percutaneous Mitral Valve Replacement (PMVR).
|
CardioMag Imaging, Inc.
Schenectady, NY
|
Non-invasive devices to identify patients with coronary artery disease and other life threatening cardiovascular conditions.
www.cardiomag.com
|
CoreSpine Technologies
Minneapolis, MN
|
Prepares the spinal disc for a nucleus replacement or minimally-invasive fusion device.
www.corespinetech.com
|
CorNova Inc. (First-Time Presenter)
Burlington, MA
|
Develops next-generation endovascular devices that incorporate advanced fiber optics technology into currently used products and procedures to improve patient outcomes without adding to procedure time and cost. www.cornova.com
|
CytoSorbents, Inc.
Monmouth Junction, NJ
|
CytoSorb™ is a proprietary blood purification resin in clinical trials to treat severe sepsis or “overwhelming infection” by reducing cytokine storm; a major cause of organ failure and death in sepsis.
www.cytosorbents.com
|
DiFUSION Technologies (First-Time Presenter)
Austin, TX
|
Reducing the rising incidence of Surgical Site Infections (SSIs) in spinal surgeries.
www.difusiontech.com
|
Echo Therapeutics (First-Time Presenter)
Franklin, MA
|
Company description coming soon. www.echotx.com
|
EyeGate Pharmaceuticals, Inc
Waltham, MA
|
EyeGate® II uses iontophoresis technology to safely and non-invasively deliver therapeutics for ocular indications.
www.eyegatepharma.com
|
ICON Interventional Systems (First-Time Presenter)
Atlanta, GA
|
Emerging, medical device company providing cardiovascular solutions to patients and doctors around the world.
www.icon-us.com
|
Invendo Medical GmbH
Kissing, Germany
|
Improves the convenience and tolerability of gastroenterological endoscopic procedures, resulting in better patient compliance and increased procedure(s) performed.
www.invendo-medical.com
|
Medical Device Works
Brussells, Belgium
|
The only set of catheters for percutaneous isolation of an organ (liver) and local delivery of (any) high dosage chemotherapy for treatment of organ cancer. www.medicaldeviceworks.com
|
Mespere Lifesciences, Inc. (First-Time Presenter)
Waterloo, Canada
|
Non-invasive monitoring of Central Venous Pressure (CVP) for cardiology and nephrology diagnostic applications.
www.mespere.com
|
Methco (First-Time Presenter)
Toronto, Canada
|
Developing a disposable delivery device to improve asthma and COPD (Chronic Obstructive Pulmonary Disease) diagnosis and ongoing disease management of asthmatics and other respiratory conditions.
|
MiCardia Corporation (First-Time Presenter)
Irvine, CA
|
Company description coming soon. www.micardia.com
|
MicroMed Cardiovascular Inc. (First-Time Presenter)
Houston, TX
|
A pioneer in the accelerating field of Mechanical Circulatory Support. MicroMed manufactures a small implantable electric pump, the HeartAssist5, developed by NASA and famed heart surgeon Dr. Michael E. DeBakey that is intended to increase the cardiac output of a patient with a failing heart. www.micromedcv.com
|
MicroPhage Inc.
Longmont, CO
|
Bacteriophage enabling technology that offers the ability to increase specificity and decrease time to results on existing immunodiagnostic platforms.
www.micro-phage.com
|
MicroTransponder Inc.
Dallas, TX
|
Developed a wireless neurostimulation device to treat refractory chronic pain. It is 100 times smaller than the current technology and injectable via a minimally invasive hypodermic needle.
www.microtransponder.com
|
Nonatec Medical (First-Time Presenter)
Princeton, NJ
|
Company description coming soon.
|
NuOrtho Surgical Inc. (First-Time Presenter)
Fall River, MA
|
Low level radio frequency energy that is combined with instruments and therapeutic agents designed to protect the treatment site during use and promote tissue healing and patient recovery. www.nuorthosurgical.com
|
Optasia Medical, Ltd. (First-Time Presenter)
Sudbury, MA
|
Serving the needs of the large and growing market of musculoskeletal disease with highly scalable, high margin, proprietary medical image analysis software products.
www.optasiamedical.com
|
Pico-Tesla Magentic Therapies, LLC
Littleton, CO
|
Later-stage, web-enabled, non invasive, neuromodulation platform technology company, beginning a phase III Clinical trial (2009) involving Parkinson’s Disease.
|
PLC Medical Systems, Inc. (First-Time Presenter)
Franklin, MA
|
Company description coming soon. www.plcmed.com
|
Profound Medical Inc. (First-Time Presenter)
Ontario, Canada
|
Commercialising a unique, minimally-invasive approach for the treatment of prostate cancer.
www.profoundmedical.com
|
Replication Medical, Inc. (RMI)
Cranbury, NJ
|
Implantable hydrogel devices to be used for treating degenerative disc disease.
www.replicationmedical.com
|
Spartan Bioscience Inc. (First-Time Presenter)
Ottowa, Canada
|
Canadian molecular diagnostics company that develops, manufactures, and markets DNA analyzers for on-demand applications. www.spartanbio.com
|
Spinetronics LLC (First-Time Presenter)
Coral Springs, FL
|
Invented the Antalgic-Trak. The only articulating range of motion non surgical spinal decompression system. Treats herniated, bulged and injured discs. Current research reveals 95% treatment success with a 1 year patient satisfaction follow up of 86%. There are 40 systems across the US, Canada and Asia. www.Spinetronics.com
|
SpinX Technologies, SA
Geneva, Switzerland
|
SpinX Technologies develops and commercializes a programmable lab-on-a-chip platform, for applications ranging from drug discovery to in-vitro diagnostics. www.spinx-technologies.com
|
SquareOne Inc. (First-Time Presenter)
Mountain View, CA
|
Internationally launching an aorto-ostial stent system for use in both peripheral and coronary ostial lesions.
www.squareone-inc.com
|
SynCardia Systems, Inc. (First-Time Presenter)
Tucson, AZ
|
World’s only FDA & CE approved Total Artificial Heart manufacturer to submit 12 lb Freedom™ discharge driver to FDA & CE in Q2/Q3.
www.syncardia.com
|
ThermalAngel (First-Time Presenter)
Dallas, TX
|
In-line, battery-powered disposable, lightweight and completely portable blood and IV fluid warming device, capable of intravenous application and irrigation warming. www.thermalangel.com
|
Veryan Medical, Ltd.
West Sussex, United Kingdom
|
Vascular stents and grafts with increased patency by improved flow dynamics, reducing stenosis and restenosis.
www.veryanmed.com
|
VivoMetrics. Inc.
Ventura, CA
|
Next generation remote patient monitoring (RPM) - LifeShirt - continuously monitors vital life-sign functions such as heart rate, respiratory rate, body position, activity level and skin temperature.
www.vivometrics.com
|
Xylos Corporation
Langhorne, PA
|
Medical device company that develops unique biomaterials based on proprietary biocellulose technology for the treatment, repair, or placement of human tissue.
www.xyloscorp.com
|
|
*Cancellation
Policy: Refunds will only be given through May 23, 2009. Paid cancellations thru May 23, 2009 will incur a $300 processing fee. Cancellations after May 23, 2009 will only be allowed a replacement attendee. No other credit, transfer, or refund will be offered.
|
| |
|
Sponsored
by:
Major Supporting Publications
Official Wire Service for In3 Conferences
|
|
